Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Kristina Maas-Bauer

Showing results (1-10 of 21) with videos related to

Pageof 3
Sort By:
Frontiers in Immunology|August 22, 2017
Invariant Natural Killer T Cells As Suppressors of Graft-versus-Host Disease in Allogeneic Hematopoietic Stem Cell TransplantationMelissa Mavers, Kristina Maas-Bauer, Robert S Negrin
Bone Marrow Transplantation|November 20, 2024
Immunological reconstitution and infections after alloHCT - a comparison between post-transplantation cyclophosphamide, ATLG and non-ATLG based GvHD prophylaxisThomas Meyer, Kristina Maas-Bauer, Ralph Wäsch, et al.
Frontiers in Immunology|January 25, 2021
Infusion of Host-Derived Unlicensed NK Cells Improves Donor Engraftment in Non-Myeloablative Allogeneic Hematopoietic Cell TransplantationMaite Alvarez, Antonio Pierini, Federico Simonetta, et al.
Bone Marrow Transplantation|November 18, 2020
Ruxolitinib-ECP combination treatment for refractory severe chronic graft-versus-host diseaseKristina Maas-Bauer, Chrissoula Kiote-Schmidt, Hartmut Bertz, et al.
Blood Advances|June 8, 2021
Activation of natural killer T cells enhances the function of regulatory T-cell therapy in suppressing murine GVHDToshihito Hirai, Po-Yu Lin, Federico Simonetta, et al.
British Journal of Haematology|November 26, 2024
Genocopy of EVI1-AML with paraneoplastic diabetes insipidus: PRDM16 overexpression by t(1;2)(p36;p21) and enhancer hijackingJulian List, Etienne Sollier, Fiona Brown-Burke, et al.
Frontiers in Immunology|August 6, 2019
Activation of the DR3-TL1A Axis in Donor Mice Leads to Regulatory T Cell Expansion and Activation With Reduction in Graft-Versus-Host DiseaseMelissa Mavers, Federico Simonetta, Hidekazu Nishikii, et al.
Blood|October 21, 2016
DR3 signaling modulates the function of Foxp3+ regulatory T cells and the severity of acute graft-versus-host diseaseHidekazu Nishikii, Byung-Su Kim, Yasuhisa Yokoyama, et al.
British Journal of Haematology|July 30, 2025
The importance of systemic inflammatory response measurements as pretransplant risk factors for outcome after allogeneic haematopoietic cell transplantationHartmut Bertz, Jörg Sahlmann, Donald C McMillan, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|August 11, 2021
Allogeneic CAR Invariant Natural Killer T Cells Exert Potent Antitumor Effects through Host CD8 T-Cell Cross-PrimingFederico Simonetta, Juliane K Lohmeyer, Toshihito Hirai, et al.
Pageof 3

Showing results (1-10 of 21) with videos related to

Sort By:
Pageof 3
Frontiers in Immunology|August 22, 2017
Invariant Natural Killer T Cells As Suppressors of Graft-versus-Host Disease in Allogeneic Hematopoietic Stem Cell TransplantationMelissa Mavers, Kristina Maas-Bauer, Robert S Negrin
Bone Marrow Transplantation|November 20, 2024
Immunological reconstitution and infections after alloHCT - a comparison between post-transplantation cyclophosphamide, ATLG and non-ATLG based GvHD prophylaxisThomas Meyer, Kristina Maas-Bauer, Ralph Wäsch, et al.
Frontiers in Immunology|January 25, 2021
Infusion of Host-Derived Unlicensed NK Cells Improves Donor Engraftment in Non-Myeloablative Allogeneic Hematopoietic Cell TransplantationMaite Alvarez, Antonio Pierini, Federico Simonetta, et al.
Bone Marrow Transplantation|November 18, 2020
Ruxolitinib-ECP combination treatment for refractory severe chronic graft-versus-host diseaseKristina Maas-Bauer, Chrissoula Kiote-Schmidt, Hartmut Bertz, et al.
Blood Advances|June 8, 2021
Activation of natural killer T cells enhances the function of regulatory T-cell therapy in suppressing murine GVHDToshihito Hirai, Po-Yu Lin, Federico Simonetta, et al.
British Journal of Haematology|November 26, 2024
Genocopy of EVI1-AML with paraneoplastic diabetes insipidus: PRDM16 overexpression by t(1;2)(p36;p21) and enhancer hijackingJulian List, Etienne Sollier, Fiona Brown-Burke, et al.
Frontiers in Immunology|August 6, 2019
Activation of the DR3-TL1A Axis in Donor Mice Leads to Regulatory T Cell Expansion and Activation With Reduction in Graft-Versus-Host DiseaseMelissa Mavers, Federico Simonetta, Hidekazu Nishikii, et al.
Blood|October 21, 2016
DR3 signaling modulates the function of Foxp3+ regulatory T cells and the severity of acute graft-versus-host diseaseHidekazu Nishikii, Byung-Su Kim, Yasuhisa Yokoyama, et al.
British Journal of Haematology|July 30, 2025
The importance of systemic inflammatory response measurements as pretransplant risk factors for outcome after allogeneic haematopoietic cell transplantationHartmut Bertz, Jörg Sahlmann, Donald C McMillan, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|August 11, 2021
Allogeneic CAR Invariant Natural Killer T Cells Exert Potent Antitumor Effects through Host CD8 T-Cell Cross-PrimingFederico Simonetta, Juliane K Lohmeyer, Toshihito Hirai, et al.
Pageof 3